The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Thomas J. Walsh

Pediatric Oncology Branch

National Cancer Institute

Bethesda

MD 20892

USA

[email]@mail.nih.gov

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD 20892, USA. 2000 - 2009
  • Mycology Unit and Immunocompromised Host Section, National Institutes of Health, Bethesda, Maryland 20892, USA. 2000

References

  1. Pneumocystis pneumonia in children. Pyrgos, V., Shoham, S., Roilides, E., Walsh, T.J. Paediatr. Respir. Rev (2009) [Pubmed]
  2. Diagnostic imaging of experimental invasive pulmonary aspergillosis. Walsh, T.J., Petraitis, V., Petraitiene, R., Solomon, J., Bacher, J.D., Greene, L., Cotton, M., Groll, A., Roilides, E., Avila, N., Pyrgos, V., Shoham, S. Med. Mycol. (2009) [Pubmed]
  3. Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial. Walsh, T.J., Raad, I., Patterson, T.F., Chandrasekar, P., Donowitz, G.R., Graybill, R., Greene, R.E., Hachem, R., Hadley, S., Herbrecht, R., Langston, A., Louie, A., Ribaud, P., Segal, B.H., Stevens, D.A., van Burik, J.A., White, C.S., Corcoran, G., Gogate, J., Krishna, G., Pedicone, L., Hardalo, C., Perfect, J.R. Clin. Infect. Dis. (2007) [Pubmed]
  4. Control, immunoregulation, and expression of innate pulmonary host defenses against Aspergillus fumigatus. Walsh, T.J., Roilides, E., Cortez, K., Kottilil, S., Bailey, J., Lyman, C.A. Med. Mycol. (2005) [Pubmed]
  5. Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents. Walsh, T.J., Adamson, P.C., Seibel, N.L., Flynn, P.M., Neely, M.N., Schwartz, C., Shad, A., Kaplan, S.L., Roden, M.M., Stone, J.A., Miller, A., Bradshaw, S.K., Li, S.X., Sable, C.A., Kartsonis, N.A. Antimicrob. Agents Chemother. (2005) [Pubmed]
  6. Infections due to emerging and uncommon medically important fungal pathogens. Walsh, T.J., Groll, A., Hiemenz, J., Fleming, R., Roilides, E., Anaissie, E. Clin. Microbiol. Infect. (2004) [Pubmed]
  7. Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration. Walsh, T.J., Karlsson, M.O., Driscoll, T., Arguedas, A.G., Adamson, P., Saez-Llorens, X., Vora, A.J., Arrieta, A.C., Blumer, J., Lutsar, I., Milligan, P., Wood, N. Antimicrob. Agents Chemother. (2004) [Pubmed]
  8. Efficacy of PLD-118, a novel inhibitor of candida isoleucyl-tRNA synthetase, against experimental oropharyngeal and esophageal candidiasis caused by fluconazole-resistant C. albicans. Petraitis, V., Petraitiene, R., Kelaher, A.M., Sarafandi, A.A., Sein, T., Mickiene, D., Bacher, J., Groll, A.H., Walsh, T.J. Antimicrob. Agents Chemother. (2004) [Pubmed]
  9. Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction. Walsh, T.J., Shoham, S., Petraitiene, R., Sein, T., Schaufele, R., Kelaher, A., Murray, H., Mya-San, C., Bacher, J., Petraitis, V. J. Clin. Microbiol. (2004) [Pubmed]
  10. Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B. Walsh, T.J., Petraitis, V., Petraitiene, R., Field-Ridley, A., Sutton, D., Ghannoum, M., Sein, T., Schaufele, R., Peter, J., Bacher, J., Casler, H., Armstrong, D., Espinel-Ingroff, A., Rinaldi, M.G., Lyman, C.A. J. Infect. Dis. (2003) [Pubmed]
  11. Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children. Walsh, T.J., Lutsar, I., Driscoll, T., Dupont, B., Roden, M., Ghahramani, P., Hodges, M., Groll, A.H., Perfect, J.R. Pediatr. Infect. Dis. J. (2002) [Pubmed]
  12. Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study. Walsh, T.J., Goodman, J.L., Pappas, P., Bekersky, I., Buell, D.N., Roden, M., Barrett, J., Anaissie, E.J. Antimicrob. Agents Chemother. (2001) [Pubmed]
  13. Overview: non-fumigatus species of Aspergillus: perspectives on emerging pathogens in immunocompromised hosts. Walsh, T.J., Groll, A.H. Curr. Opin. Investig. Drugs (2001) [Pubmed]
  14. Correlation between in vitro and in vivo antifungal activities in experimental fluconazole-resistant oropharyngeal and esophageal candidiasis. Walsh, T.J., Gonzalez, C.E., Piscitelli, S., Bacher, J.D., Peter, J., Torres, R., Shetti, D., Katsov, V., Kligys, K., Lyman, C.A. J. Clin. Microbiol. (2000) [Pubmed]
  15. Dose-dependent pharmacokinetics of amphotericin B lipid complex in rabbits. Walsh, T.J., Jackson, A.J., Lee, J.W., Amantea, M., Sein, T., Bacher, J., Zech, L. Antimicrob. Agents Chemother. (2000) [Pubmed]
  16. Concepts in design of comparative clinical trials of antifungal therapy in neutropenic patients. Walsh, T.J., Roden, M., Roilides, E., Groll, A. Int. J. Antimicrob. Agents (2000) [Pubmed]
  17. New targets and delivery systems for antifungal therapy. Walsh, T.J., Viviani, M.A., Arathoon, E., Chiou, C., Ghannoum, M., Groll, A.H., Odds, F.C. Med. Mycol. (2000) [Pubmed]
 
WikiGenes - Universities